These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31115327)

  • 1. [Interleukin-33: from biology to potential treatments].
    Schmitt P; Girard JP; Cayrol C
    Med Sci (Paris); 2019 May; 35(5):440-451. PubMed ID: 31115327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL33: Roles in Allergic Inflammation and Therapeutic Perspectives.
    Chan BCL; Lam CWK; Tam LS; Wong CK
    Front Immunol; 2019; 10():364. PubMed ID: 30886621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
    Cayrol C; Girard JP
    Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
    Cayrol C; Girard JP
    Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity.
    Cayrol C
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines.
    Tettamanti L; Kritas SK; Gallenga CE; D'Ovidio C; Mastrangelo F; Ronconi G; Caraffa Al; Toniato E; Conti P
    J Biol Regul Homeost Agents; 2018; 32(5):1061-1065. PubMed ID: 30334399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
    Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
    Front Immunol; 2018; 9():2004. PubMed ID: 30233590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33.
    Cayrol C; Duval A; Schmitt P; Roga S; Camus M; Stella A; Burlet-Schiltz O; Gonzalez-de-Peredo A; Girard JP
    Nat Immunol; 2018 Apr; 19(4):375-385. PubMed ID: 29556000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-33 and Behçet disease: Another cytokine among others.
    Hamzaoui K; Bouali E; Hamzaoui A
    Hum Immunol; 2015 May; 76(5):301-6. PubMed ID: 25814446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL33/ST2 Axis in Diabetic Kidney Disease: A Literature Review.
    Tonacci A; Quattrocchi P; Gangemi S
    Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30769901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.
    Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
    Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-33 and its Receptor in Pulmonary Inflammatory Diseases.
    Zhao J; Zhao Y
    Crit Rev Immunol; 2015; 35(6):451-61. PubMed ID: 27279043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.
    Schwartz C; O'Grady K; Lavelle EC; Fallon PG
    Eur J Immunol; 2016 May; 46(5):1091-100. PubMed ID: 27000936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
    Chen WY; Tsai TH; Yang JL; Li LC
    Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Alarmin IL-33 Derived from HSV-2-Infected Keratinocytes Triggers Mast Cell-Mediated Antiviral Innate Immunity.
    Aoki R; Kawamura T; Goshima F; Ogawa Y; Nakae S; Moriishi K; Nakao A; Shimada S
    J Invest Dermatol; 2016 Jun; 136(6):1290-1292. PubMed ID: 26872602
    [No Abstract]   [Full Text] [Related]  

  • 16. IL-33's role in the gut immune system: A comprehensive review of its crosstalk and regulation.
    Kaur H; Kaur G; Ali SA
    Life Sci; 2023 Aug; 327():121868. PubMed ID: 37330043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous IL-33 Contributes to Kidney Ischemia-Reperfusion Injury as an Alarmin.
    Ferhat M; Robin A; Giraud S; Sena S; Goujon JM; Touchard G; Hauet T; Girard JP; Gombert JM; Herbelin A; Thierry A
    J Am Soc Nephrol; 2018 Apr; 29(4):1272-1288. PubMed ID: 29436517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin (IL)-33 and the IL-1 Family of Cytokines-Regulators of Inflammation and Tissue Homeostasis.
    Vasanthakumar A; Kallies A
    Cold Spring Harb Perspect Biol; 2019 Mar; 11(3):. PubMed ID: 29101106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichotomous function of IL-33 in health and disease: From biology to clinical implications.
    Braun H; Afonina IS; Mueller C; Beyaert R
    Biochem Pharmacol; 2018 Feb; 148():238-252. PubMed ID: 29309756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interleukin-33 receptors are expressed in early progenitor stages of allergy-related granulocytes.
    Tsuzuki H; Arinobu Y; Miyawaki K; Takaki A; Ota SI; Ota Y; Mitoma H; Akahoshi M; Mori Y; Iwasaki H; Niiro H; Tsukamoto H; Akashi K
    Immunology; 2017 Jan; 150(1):64-73. PubMed ID: 27568595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.